QDEL

Quidel

17.04

+0.46+2.77%

Opening12:10 04/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE15.95/16.58

TODAY RANGE15.55-17.55

VOL378.77K

MARKET CAP1.16B

52 WEEK RANGE14.45-38.99

AVG VOL (3M)1.43M

% TURNOVER0.56%

TURNOVER--

P/E (TTM)-1.0208

% RANGE12.06%

EPS(TTM)-16.6932

P/E(FORWARD)-12.7164

P/B0.6025

BVPS28.28

DIVIDEND--

P/S0.4238

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.14B

SHARES OUTSTANDING68.08M

NEXT EARNINGS05/05-05/11

FREE FLOAT66.93M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Reuters·1d ago
QuidelOrtho CLO Nathaniel Sisitsky files initial beneficial ownership statement
Reuters·03/24 20:41
QuidelOrtho EVP Global Portfolio Management and Marketing Bryan Michael Hanson files initial beneficial ownership statement
TipRanks·03/24 11:32
QuidelOrtho Announces Chief Legal Officer Leadership Transition
Reuters·03/24 11:01
QuidelOrtho names Nathaniel Sisitsky chief legal officer
Dow Jones·03/24 11:00
Press Release: Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
Dow Jones·03/24 11:00
*Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
TipRanks·03/16 15:05
Rising helium prices could create headwind for Bruker, says Jefferies
Simply Wall St·03/02 15:15
A Look At QuidelOrtho (QDEL) Valuation After New Lifotronic Supply Agreement
TipRanks·02/27 11:30
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), QuidelOrtho (QDEL) and Akebia Therapeutics (AKBA)
Simply Wall St·02/27 10:32
Should QuidelOrtho’s (QDEL) Lifotronic Immunoassay Expansion Require Action From QDEL Investors?
Simply Wall St·02/25 06:41
Has QuidelOrtho (QDEL) Become A Potential Opportunity After Its Sharp Share Price Slide
TipRanks·02/20 06:05
Quidelortho Faces Material Risk from Weak Internal Controls and Sarbanes–Oxley Compliance Challenges
Reuters·02/19 14:17
QuidelOrtho Manager Says High-Sensitivity Troponin Speeds Heart Attack Diagnosis
PR Newswire·02/19 14:17
Faster Cardiac Answers with High‑Sensitivity Troponin
Reuters·02/19 11:04
QuidelOrtho FY 2025 Donor Screening revenue falls 54% to USD 52.6 million

Same Industry

Name/Symbol

Change%

Price

QDEL

Thermo Fishr Sci

TMO

+0.61%

494.54

WAT

Fulgent Genetics

FLGT

+0.26%

15.63

Danaher Corporation

DHR

-3.27%

181.52

RMD

Check Point Software Tech Ltd

CHKP

-2.79%

138.84

ABMD

GEHC

Intuitive Surgical Inc

ISRG

-3.39%

452.66

Veeva Sys Inc

VEEV

-0.17%

175.66

Revvity Inc

RVTY

-3.70%

83.90

Edwards Lifesciences Corp

+1.47%

81.26

INMD

ATHN

Bruker Corp

BRKR

-4.58%

33.72

VARIAN MEDICAL

VAR

0.00%

0.0000

Integer Hldgs Corp

ITGR

+3.33%

88.00

Hologic Inc

HOLX

-0.03%

75.67

Cerner Corp

CERN

0.00%

94.92

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.